Greenstreet Yvonne Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
24
Insider Sells Sum
$54.46M

Insider Activity of Greenstreet Yvonne

According to the SEC Form 4 filings, Greenstreet Yvonne, being in a position of

  1. Chief Executive Officer at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 51917 shares for $20.42M,
    over all time since 2018-03-26, has bought 0 shares, and sold 415024 shares for $95.73M.

Biography of Greenstreet Yvonne

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $20,420,9826100

Comparison of Insiders on Amount of Buys and Sells

2026-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
2,933
0.0022%
$323.08$947,581-12.54%
2026-03-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
6,799
0.005%
$327.65$2.23M-11.89%
2026-02-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
6,958
0.0052%
$310.08$2.16M-8.34%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
9,577
0.0071%
$362.86$3.48M-20.79%
2025-11-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
10,000
0.0075%
$451.27$4.51M-33.45%
2025-11-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
15,650
0.0121%
$453.69$7.1M-33.17%
2025-10-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
8,924
0.0067%
$452.05$4.03M-31.16%
2025-08-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
6,979
0.0053%
$453.27$3.16M-27.2%
2025-06-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
19,297
0.0148%
$306.00$5.9M+14.93%
2025-05-30SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
25,469
0.0195%
$304.00$7.74M+15.54%
2025-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
3,877
0.003%
$243.79$945,165+44.46%
2025-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
2,900
0.0022%
$241.69$700,894+42.61%
2025-02-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
1,213
0.0009%
$255.17$309,527+37.21%
2024-11-26SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
5,219
0.004%
$250.98$1.31M+18.3%
2024-08-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
15,000
0.0117%
$280.00$4.2M-3.49%
2024-08-01SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
15,148
0.012%
$270.00$4.09M+0.28%
2024-07-11SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
7,093
0.006%
$261.00$1.85M+2%
2024-06-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
8,301
0.0063%
$230.99$1.92M+9.36%
2024-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
2,932
0.0023%
$155.31$455,357+58.99%
2024-02-16SaleAlnylam Pharmaceuticals, Inc.
ALNY
Chief Executive Officer
7,030
0.0056%
$148.06$1.04M+66.97%
Total: 34
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.